The biology of cachectin/TNF--a primary mediator of the host response.

Inflammation, the most ancient aspect of the host immune response, is surely of great value to the host, insofar as agents that suppress inflam­ mation in a nonspecific fashion predispose to infection. Yet, the inflam­ matory response to invasive organisms may also, if sufficiently intense or inappropriately prolonged, cause injury or death. A delicate balance has thus been achieved, one which clinicians strive to maintain through judicious application of anti-inflammatory medications (e.g. glucocorti­ coids, nonsteroidal anti-inflammatory agents, and cytotoxic drugs). Only recently have we come to understand that many aspects of this primitive response to host invasion are governed by polypeptide hormones, in turn produced by immune effector cells. Moreover, we have come to appreciate the pleiotropic properties of these so-called "cytokines." It would appear that a ' limited number of cytokines are capable of orches­ trating disease states that scarcely resemble one another; among them, endotoxic shock, graft-vs-host disease, cerebral malaria, and cancer cachexia. Cells of monocyte/macrophage lineage play a central role in cytokine ("mono kine") production and so act to modulate many aspects of the inflammatory response. While devoid of specificity and immunologic mem-

[1]  M. Turner,et al.  TUMOUR NECROSIS FACTOR AS AN AUTOCRINE TUMOUR GROWTH FACTOR FOR CHRONIC B-CELL MALIGNANCIES , 1988, The Lancet.

[2]  L. F. Fajardo,et al.  Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. , 1987, Science.

[3]  J A Koziol,et al.  Evolution of the genome and the genetic code: selection at the dinucleotide level by methylation and polyribonucleotide cleavage. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[4]  P. Hotez,et al.  Lipoprotein lipase suppression in 3T3‐L1 cells by a haematoprotozoan‐induced mediator from peritoneal exudate cells , 1984, Parasite immunology.

[5]  H. Holtmann,et al.  Sensitization and desensitization to lethal effects of tumor necrosis factor and IL-1. , 1988, Journal of immunology.

[6]  B. Aggarwal,et al.  Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. , 1985, Journal of immunology.

[7]  B. Aggarwal,et al.  Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. , 1985, Science.

[8]  B. Beutler,et al.  Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[9]  R. Hornung,et al.  Target cell DNA fragmentation is mediated by lymphotoxin and tumor necrosis factor. , 1987, Lymphokine research.

[10]  D. Kufe,et al.  Expression of tumor necrosis factor receptors on human monocytes and internalization of receptor bound ligand. , 1987, Journal of immunology.

[11]  K. Manogue,et al.  Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. , 1988, Science.

[12]  Z. Darżynkiewicz,et al.  Cell cycle-specific effects of tumor necrosis factor. , 1984, Cancer research.

[13]  G. Trinchieri,et al.  Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes , 1987, The Journal of experimental medicine.

[14]  A. Cerami,et al.  Effect of endotoxin-induced monokines on glucose metabolism in the muscle cell line L6. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[15]  T. Decker,et al.  Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages. , 1987, Journal of immunology.

[16]  P. Cuatrecasas,et al.  Cellular receptor for 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[17]  H. Northoff,et al.  Endotoxic activities of tumor necrosis factor independent of IL1 secretion by macrophages/monocytes. , 1987, Lymphokine research.

[18]  J. Abbott,et al.  Ontogeny of murine T lymphocytes. I. Maturation of thymocytes induced in vitro by tumor necrosis factor-positive serum (TNF+)1,2. , 1981, Cellular immunology.

[19]  J. D. Albert,et al.  Materials and Methods Brief Definitive Report CACHECTIN/TUMOR NECROSIS FACTOR MEDIATES CHANGES OF SKELETAL MUSCLE PLASMA MEMBRANE POTENTIAL , 2022 .

[20]  P. Scheurich,et al.  Quantification and characterization of high‐affinity membrane receptors for tumor necrosis factor on human leukemic cell lines , 1986, International journal of cancer.

[21]  R. Wallis,et al.  Tumor necrosis factor is the major monocyte product that increases complement receptor expression on mature human neutrophils. , 1988, Blood.

[22]  N. Matthews Tumour-necrosis factor from the rabbit. II. Production by monocytes. , 1978, British Journal of Cancer.

[23]  L. Bermudez,et al.  Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex. , 1988, Journal of immunology.

[24]  A. Oliff,et al.  Tumors secreting human TNF/cachectin induce cachexia in mice , 1987, Cell.

[25]  H. Holtmann,et al.  Binding of human TNF-α to high-affinity cell surface receptors: Effect of IFN , 1986 .

[26]  B. Meyrick,et al.  Interactions of granulocytes with the lungs. , 1984, Circulation research.

[27]  H. Friedman,et al.  Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor. , 1986, Journal of immunology.

[28]  J. Vilček,et al.  Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors , 1986, The Journal of experimental medicine.

[29]  W. Fiers,et al.  Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers. , 1986, The American journal of pathology.

[30]  C. Dinarello,et al.  Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. , 1986, Science.

[31]  A. Cerami,et al.  Selective inhibition of synthesis of enzymes for de novo fatty acid biosynthesis by an endotoxin-induced mediator from exudate cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. D. Albert,et al.  Shock and tissue injury induced by recombinant human cachectin. , 1986, Science.

[33]  A. Mantovani,et al.  Interleukin-1 induces c-fos protooncogene expression in cultured human endothelial cells. , 1988, Biochemical and biophysical research communications.

[34]  N. Sato,et al.  Actions of tumor necrosis factor on cultured vascular endothelial cells: morphologic modulation, growth inhibition, and cytotoxicity. , 1986, Journal of the National Cancer Institute.

[35]  G. Shaw,et al.  A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation , 1986, Cell.

[36]  J. David,et al.  Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Playfair,et al.  Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum. , 1984, Clinical and experimental immunology.

[38]  J. Saklatvala Tumour necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage , 1986, Nature.

[39]  H. Shin,et al.  Tumor necrosis factor-mediated cytotoxicity involves ADP-ribosylation. , 1988, Journal of immunology.

[40]  L. Chedid,et al.  Enhancement of resistance to infections by endotoxin-induced serum factor from Mycobacterium bovis BCG-infected mice , 1980, Infection and immunity.

[41]  C. Galanos,et al.  Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice , 1987, The Journal of experimental medicine.

[42]  J. Coalson,et al.  Significance of leukocytes in endotoxic shock. , 1974, Experimental and molecular pathology.

[43]  W. Fiers,et al.  The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[44]  I. Clark,et al.  Possible roles of tumor necrosis factor in the pathology of malaria. , 1987, The American journal of pathology.

[45]  T. Niijima,et al.  Cytotoxic effect of tumor necrosis factor on human lymphocytes and specific binding of the factor to the target cells. , 1983, Cellular and molecular biology.

[46]  J. Tavernier,et al.  EVIDENCE FOR TUMOUR NECROSIS FACTOR/CACHECTIN PRODUCTION IN CANCER , 1987, The Lancet.

[47]  F. Bauss,et al.  Tumor necrosis factor mediates endotoxic effects in mice , 1987, Infection and immunity.

[48]  H. Koren,et al.  Lipopolysaccharide (LPS) stimulates fresh human monocytes to lyse actinomycin D-treated WEHI-164 target cells via increased secretion of a monokine similar to tumor necrosis factor. , 1985, Journal of immunology.

[49]  J. Kuhn,et al.  Tumor necrosis factor not detectable in patients with clinical cancer cachexia. , 1988, Journal of the National Cancer Institute.

[50]  G. Trinchieri,et al.  Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon , 1985, The Journal of experimental medicine.

[51]  A. Cerami,et al.  Lipoprotein lipase suppression in 3T3-L1 cells by an endotoxin-induced mediator from exudate cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[52]  J. Gamble,et al.  Stimulation of neutrophils by tumor necrosis factor. , 1986, Journal of immunology.

[53]  N. Rothwell Central effects of TNFα on thermogenesis and fever in the rat , 1988, Bioscience reports.

[54]  K. Takeda,et al.  Identity of differentiation inducing factor and tumour necrosis factor , 1986, Nature.

[55]  R L Kassel,et al.  An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Kevin J. Tracey,et al.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia , 1987, Nature.

[57]  B. Beutler,et al.  A macrophage factor inhibits adipocyte gene expression: an in vitro model of cachexia. , 1985, Science.

[58]  B. Waksman,et al.  Cytotoxic Effect of Lymphocyte-Antigen Interaction in Delayed Hypersensitivity , 1967, Science.

[59]  D. Kufe,et al.  Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes. , 1988, The Journal of clinical investigation.

[60]  J. Larrick,et al.  Tumor necrosis factor stimulates interleukin-1 and prostaglandin E2 production in resting macrophages. , 1986, Biochemical and biophysical research communications.

[61]  A. Waage,et al.  ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASE , 1987, The Lancet.

[62]  H. Rokita,et al.  Limited effects of recombinant human and murine interleukin 1 and tumour necrosis factor on production of acute phase proteins by cultured rat hepatocytes. , 1987, Biochemistry international.

[63]  T. Shirai,et al.  Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor , 1985, Nature.

[64]  B. Beutler,et al.  Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells , 1985, The Journal of experimental medicine.

[65]  N. Matthews Tumour-necrosis factor from the rabbit. V. Synthesis in vitro by mononuclear phagocytes from various tissues of normal and BCG-injected rabbits. , 1981, British Journal of Cancer.

[66]  B. Beutler,et al.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. , 1985, Science.

[67]  J. David,et al.  Characterization of a factor from the U937 cell line that enhances the toxicity of human eosinophils to Schistosoma mansoni larvae. , 1987, Journal of Immunology.

[68]  P. Ghezzi,et al.  Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor , 1988, The Journal of experimental medicine.

[69]  J. D. Albert,et al.  Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. , 1987, Surgery, gynecology & obstetrics.

[70]  B. Beutler,et al.  Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. , 1985, Journal of immunology.

[71]  Harold V. Gaskill Continuous infusion of tumor necrosis factor: mechanisms of toxicity in the rat. , 1988, The Journal of surgical research.

[72]  J. Dipersio,et al.  Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor. , 1986, Journal of immunology.

[73]  H. Ochs,et al.  An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor-alpha increases neutrophil adherence by a CDw18-dependent mechanism. , 1986, Journal of immunology.

[74]  J. Tavernier,et al.  Tissue-specific regulation of guinea pig lipoprotein lipase; effects of nutritional state and of tumor necrosis factor on mRNA levels in adipose tissue, heart and liver. , 1988, Gene.

[75]  C. Jacob,et al.  Tumour necrosis factor-α in murine autoimmune 'lupus' nephritis , 1988, Nature.

[76]  J. Playfair,et al.  Differential sensitivity in vivo of lethal and nonlethal malarial parasites to endotoxin-induced serum factor , 1982, Infection and immunity.

[77]  I. Clark,et al.  Macrophages from Babesia and malaria infected mice are primed for monokine release , 1984, Parasite immunology.

[78]  J. Haynes,et al.  Serum containing tumor necrosis factor is cytotoxic for the human malaria parasite Plasmodium falciparum , 1983, Infection and immunity.

[79]  M. Gimbrone,et al.  Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. , 1988, The Journal of biological chemistry.

[80]  W. Coley,et al.  THE TREATMENT OF MALIGNAT TUMORS BY REPEATED INOCULATIONS OF ERYSIPELAS: WITH A REPORT OF TEN ORIGINAL CASES , 1893 .

[81]  B. Beutler,et al.  Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. , 1986, Science.

[82]  T. Bringman,et al.  Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells. , 1987, The New England journal of medicine.

[83]  R. Contreras,et al.  The 3' untranslated region of the human interferon-beta mRNA has an inhibitory effect on translation. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[84]  B. Aggarwal,et al.  Modulation of receptors and cytotoxic response of tumor necrosis factor-alpha by various lectins. , 1986, The Journal of biological chemistry.

[85]  D. Goeddel,et al.  Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[86]  I. Clark DOES ENDOTOXIN CAUSE BOTH THE DISEASE AND PARASITE DEATH IN ACUTE MALARIA AND BABESIOSIS? , 1978, The Lancet.

[87]  B. Aggarwal,et al.  Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[88]  J. Gamble,et al.  Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[89]  R. Coombes,et al.  Changes in thermogenesis and brown fat activity in response to tumour necrosis factor in the rat , 1987, Bioscience reports.

[90]  J. Strickler,et al.  Molecular cloning of the complementary DNA for human tumor necrosis factor. , 1985, Science.

[91]  T. Bringman,et al.  Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors , 1986, Nature.

[92]  S. Natori,et al.  Induction of TNF‐like factor by murine macrophage‐like cell line J774.1 on treatment with Sarcophaga lectin , 1984, FEBS letters.

[93]  J. Mcghee,et al.  The primary role of lymphoreticular cells in the mediation of host responses to bacterial endotoxim. , 1980, The Journal of infectious diseases.

[94]  L. Chess,et al.  Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1 , 1986, The Journal of experimental medicine.

[95]  D. Niederwieser,et al.  Interferons (IFNs) and tumor necrosis factors (TNFs) in T cell-mediated immune responses against alloantigens. I. Influence on the activation of resting and antigen-primed T cells. , 1988, Immunobiology.

[96]  W. Fiers,et al.  Species specificity of human and murine tumor necrosis factor. A comparative study of tumor necrosis factor receptors. , 1986, The Journal of biological chemistry.

[97]  M. Kawakami,et al.  Human recombinant TNF suppresses lipoprotein lipase activity and stimulates lipolysis in 3T3-L1 cells. , 1987, Journal of biochemistry.

[98]  B. Waksman,et al.  CYTOTOXICITY MEDIATED BY SOLUBLE ANTIGEN AND LYMPHOCYTES IN DELAYED HYPERSENSITIVITY , 1968, The Journal of experimental medicine.

[99]  R. Yamamoto,et al.  A high molecular weight component of the human tumor necrosis factor receptor is associated with cytotoxicity. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[100]  F. Kraemer,et al.  Effects of activation on lipoprotein lipase secretion by macrophages. Evidence for autoregulation , 1986, The Journal of experimental medicine.

[101]  J. Playfair,et al.  Malarial parasites induce TNF production by macrophages. , 1988, Immunology.

[102]  J. Tavernier,et al.  Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo. , 1987, The Journal of biological chemistry.

[103]  G. Gifford,et al.  In vitro production of rabbit macrophage tumor cell cytotoxin , 1983, International journal of cancer.

[104]  W. Fiers,et al.  Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome , 1986, The Journal of experimental medicine.

[105]  D. Rosenstreich,et al.  BCG-induced enhancement of endotoxin sensitivity in C3H/HeJ mice. I. In vivo studies. , 1980, Journal of immunology.

[106]  J. Playfair,et al.  Killing of human malaria parasites by macrophage secretory products , 1984, Infection and immunity.

[107]  D. Goeddel,et al.  Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes. , 1986, Journal of immunology.

[108]  J. Sipe,et al.  Tumor necrosis factor/cachectin is a less potent inducer of serum amyloid A synthesis than interleukin 1. , 1987, Lymphokine research.

[109]  W. Fiers,et al.  Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[110]  W. Fiers,et al.  Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[111]  J. Playfair,et al.  Endotoxin-induced serum factor kills malarial parasites in vitro , 1981, Infection and immunity.

[112]  Murray J. Shear,et al.  Chemical Treatment of Tumors. V. Isolation of the Hemorrhage-Producing Fraction from Serratia marcescens (Bacillus prodigiosus) Culture Filtrate , 1943 .

[113]  P. Libby,et al.  Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. , 1986, The American journal of pathology.

[114]  T. Klein,et al.  Protective Effects of Tumor Necrosis Factor in Experimental Legionella pneumophila Infections of Mice via Activation of PMN Function , 1988, Journal of leukocyte biology.

[115]  M. Mayer,et al.  Macrophage-mediated cytotoxicity: role of a soluble macrophage cytotoxic factor similar to lymphotoxin and tumor necrosis factor. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[116]  Sergei A. Nedospasov,et al.  Nucleotide sequence of the murine TNF locus, including the TNF-α (tumor necrosis factor) and TNF-β (lymphotoxin) genes , 1987 .